A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis

Japanese Journal of Cancer Research

Volumn 89, Issue 12, 1998, Pages 1241-1250

  Tanaka, Keitaro ^a   Sakai, Hironori ^a   Hashizume, Makoto ^a   Hirohata, Tomio ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NAKAMURA GAKUEN UNIVERSITY   (Japan)

Author keywords

Cirrhosis; Follow up study; Hepatitis C virus; Hepatocellular carcinoma; Risk factor

Indexed keywords

ALPHA FETOPROTEIN; AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; SERUM ALBUMIN; VIRUS RNA;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032458317     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00520.x     Document Type: Article

References (32)

1. Colombo, M., de Franchis, R., Del Ninno, E., Sangiovanni, A., De Fazio, C., Tommasini, M., Donato, M. F., Piva, A., Di Carlo, V. and Dioguardi, N. Hepatocellular carcinoma in Italian patients with cirrhosis. N. Eugl. J. Med., 325, 675-680 (1991).
2. Oka, H., Kurioka, N., Kim, K., Kanno, T., Kuroki, T., Mizoguchi, Y. and Kobayashi, K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology, 12, 680-687 (1990).
3. Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A. and Yamazaki, H. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med., 328, 1797-1801 (1993).
4. Zaman, S. N., Melia, W. M., Johnson, R. D., Portmann, B. C., Johnson, P. J. and Williams, R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet, i, 1357-1360 (1985).
5. Ikeda, K., Saitoh, S., Koida, I., Arase, Y., Tsubota, A., Chayama, K., Kumada, H. and Kawanishi, M. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology, 18, 47-53 (1993).
6. Brechot, C. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma. Hepatology, 25, 772-774 (1997).
7. Lok, A. S. F. and Gunaratnam, N. T. Diganosis of hepatitis C. Hepatology, 26, 48S-56S (1997).
8. Perrillo, R. P. The role of liver biopsy in hepatitis C. Hepatology, 26, 57S-61S (1997).
9. Tanaka, K., Hirohata, T., Koga, S., Sugimachi, K., Kanematsu, T., Ohryohji, F., Nawata, H., Ishibashi, H., Maeda, Y., Kiyokawa, H., Tokunaga, K., Irita, Y., Takeshita, S., Arase, Y. and Nishino, N. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res., 51, 2842-2847 (1991).
10. Tanaka, K. and Hirohata, T. Relationship of hepatitis C virus genotypes and viremia levels with development of hepatocellular carcinoma among Japanese. Fukuoka Acta Med., 89, 238-248 (1998).
11. Child, C. G. and Turcotte, J. G. Surgery and portal hypertension. In "The Liver and Portal Hypertension," ed. C. G. Child, pp. 49-51 (1964). WB Saunders, Philadelphia.
12. Tanaka, K., Hirohata, T., Takeshita, S., Hirohata, I., Koga, S., Sugimachi, K., Kanematsu, T., Ohryohji, F. and Ishibashi, H. Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int. J. Cancer, 51, 509-514 (1992).
13. Okamoto, H., Sugiyama, Y., Okada, S., Kurai, K., Akahane, Y., Sugai, Y., Tanaka, T., Sato, K., Tsuda, F., Miyakawa, Y. and Mayumi, M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol., 73, 673-679 (1992).
14. Simmonds, P., Alberti, A., Alter, H. J., Bonino, F., Bradley, D. W., Brechot, C., Brouwer, J. T., Chan, S. W., Chayama, K., Chen, D. S., Choo, Q. L., Colombo, M., Cuypers, H. T. M., Date, T., Dusheiko, G. M., Esteban, J. I., Fay, O., Hadziyannis, S. J., Han, J., Hatzakis, A., Holmes, E. C., Hotta, H., Houghton, M., Irvine, B., Kohara, M., Kolberg, J. A., Kuo, G., Lau, J. Y. N., Lelie, P. N., Maertens, G., McOmish, F., Miyamura, T., Mizokami, M., Nomoto, A., Prince, A. M., Reesink, H. W., Rice, C., Roggendorf, M., Schalm, S. W., Shikata, T., Shimotohno, K., Stuyver, L., Trepo, C., Weiner, A., Yap, P. L. and Urdea, M. S. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology, 19, 1321-1324 (1994).
15. Tanaka, T., Tsukiyama-Kohara, K., Yamaguchi, K., Yagi, S., Tanaka, S., Hasegawa, A., Ohta, Y., Hattori, N. and Kohara, M. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology, 19, 1347-1353 (1994).
16. Kaplan, E. L. and Meier, P. Nonparametric estimation for incomplete observations. J. Am. Stat. Assoc., 53, 457-481 (1958).
17. SAS Institute Inc. The PHREG Procedure. In "SAS/STAT Software: Changes and Enhancements through Release 6.11," pp. 807-884 (1996). SAS Institute Inc., Cary, NC.
18. Benvegnu, L., Fattovich, G., Noventa, F., Tremolada, F., Chemello, L., Cecchetto, A. and Alberti, A. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer, 74, 2442-2448 (1994).
19. Sato, A., Kato, Y., Nakata, K., Nakao, K., Daikoku, M., Ishii, N., Matsumoto, T., Iseki, K., Mazume, H. and Nagataki, S. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis. J. Gastroenteral. Hepatol., 11, 944-948 (1996).
20. Kim, C. M., Koike, K., Saito, I., Miyamura, T. and Jay, G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature, 351, 317-320 (1991).
21. International Agency for Research on Cancer. "The Evaluation of Carcinogenic Risks to Humans: Alcohol Drinking," IARC Monographs Vol. 44, pp. 207-215 (1988). IARC, Lyon.
22. Chiba, T., Matsuzaki, Y., Abei, M., Shoda, J., Tanaka, N., Osuga, T. and Aikawa, T. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Am. J. Gastroenterol., 91, 1195-1203 (1996).
23. Kato, Y., Nakata, K., Omagari, K., Furukawa, R., Kusumoto, Y., Mori, I., Tajima, H., Tanioka, H., Yano, M. and Nagataki, S. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer, 74, 2234-2238 (1994).
24. Cottone, M., Turri, M., Caltagirone, M., Parisi, P., Orlando, A., Fiorentino, G., Virdone, R., Fusco, G., Grasso, R. and Simonetti, R. G. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alpha-fetoprotein. J. Hepatol., 21, 1029-1034 (1994).
25. Pateron, D., Ganne, N., Trinchet, J. C., Aurousseau, M. H., Mal, F., Meicler, C., Coderc, E., Reboullet, P., and Beaugrand, M. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J. Hepatol., 20, 65-71 (1994).
26. Okada, S., Sato, T., Okusaka, T., Ishii, H., Ikeda, M., Nakasuka, H., Kosakamoto, H., Yoshimori, M. and Wakabayashi, K. Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease. Br. J. Cancer, 77, 2028-2031 (1998).
27. Benvegnu, L., Pontisso, P., Cavalletto, D., Noventa, F., Chemello, L. and Alberti, A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology, 25, 211-215 (1997).
28. Bruno, S., Silini, E., Crosignani, A., Borzio, F., Leandro, G., Bono, F., Asti, M., Rossi, S., Larghi, A., Cerino, A., Podda, M. and Mondelli, M. U. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology, 25, 754-758 (1997).
29. Kobayashi, M., Tanaka, E., Sodeyama, T., Urushihara, A., Matsumoto, A. and Kiyosawa, K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology, 23, 695-699 (1996).
30. Nousbaum, J. B., Pol, S., Nalpas, B., Landais, P., Berthelot, P., Brechot, C. and the Collaborative Study Group. Hepatitis C virus type 1b (II) infection in France and Italy. Ann. Intern. Med., 122, 161-168 (1995).
31. Tanaka, K., Ikematsu, H., Hirohata, T. and Kashiwagi, S. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection. J. Natl. Cancer Inst., 88, 742-746 (1996).
32. Poynard, T., Bedossa, P., Opolon, P. and the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet, 349, 825-832 (1997).